Introduction {#s1}
============

Inflammatory monocytes (IMs) express Ly6c, CD11b and CCR2, a chemokine receptor that facilitates emigration of IMs from the bone marrow ([@bib21]). Although IMs make important contributions to innate immune defense during infection, recent studies also implicate IMs in priming of CD4 T cell responses during fungal, viral and parasitic infections ([@bib22]; [@bib11]; [@bib4]; [@bib8]; [@bib18]). Experiments using CCR2-deficient mice also suggested that monocytes contribute to T-cell-mediated defense against Mtb. IMs, however, can also serve as permissive host cells for Mtb in later stages of infection, suggesting that IMs can both restrict and enhance Mtb infection ([@bib1]). Because recruitment of IMs in CCR2-deficient mice is defective throughout early, intermediate and late stages of infection, it has not been possible to specifically define the role of monocytes at different times during infection ([@bib16]; [@bib20]; [@bib17]). Therefore, we used CCR2-DTR mice to transiently deplete IMs and other CCR2-expressing cells during discrete stages of Mtb infection.

Results and discussion {#s2}
======================

Administration of DT to these mice depletes inflammatory monocytes from the lung and mLN ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). CCR2-DTR mice that received three doses of DT surrounding the time of aerosol infection did not differ from control mice in terms of mycobacterial growth in the lungs ([Figure 1A](#fig1){ref-type="fig"}), indicating that CCR2-expressing cells are not required for the establishment of pulmonary infection following Mtb inhalation. Previous studies have demonstrated that CD4 T-cell priming occurs approximately 7--10 days following inhalational challenge ([@bib24]; [@bib7]). Depletion of CCR2-expressing cells 7, 9 and 11 days following infection resulted in a threefold increase in the number of live Mtb in the lungs on day 15 ([Figure 1B](#fig1){ref-type="fig"}). To further investigate this finding, we depleted monocytes 7--11 days following infection and quantitatively cultured Mtb from lungs and lymph nodes 12 days following infection. Although monocyte-depleted and control mice had similar Mtb CFUs in lungs at this time ([Figure 1C](#fig1){ref-type="fig"}), Mtb CFUs were markedly reduced in mLNs of mice treated with DT (1D).10.7554/eLife.01086.003Figure 1.Depletion of inflammatory monocytes during the second week of *M. tuberculosis* infection abrogates transport of live bacteria to mLNs and increases pulmonary bacterial burden.(**A**) CFU plots from the lungs of CCR2-DTR mice receiving DT or PBS on days −1, 0 and 1 and harvested on day 7. (**B**) CFU plots of the lungs of CCR2-DTR mice receiving DT or PBS on days 7, 9 and 11 and harvested on day 15 post infection. CFU counts from the lungs (**C**) and mLN (**D**) of CCR2-DTR mice given DT treatment on days 7, 9 and 11 and harvested on day 12. Each dot represents an individual mouse. Error bars denote SEM. Data are representative of two independent experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.01086.003](10.7554/eLife.01086.003)10.7554/eLife.01086.004Figure 1---figure supplement 1.DT administration depletes IMs from the lungs and mLNs of infected mice.CCR2-DTR mice received PBS or DT on days 7, 9 and 11 post infection and were harvested on day 12 when flow cytometry was performed to quantify the IM population in the lungs (**A**) and mLN (**B**). Data are representative of three independent experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.01086.004](10.7554/eLife.01086.004)

We reasoned that reducing live *M. tuberculosis* transport from the lung to the draining lymph node following monocyte depletion on days 7--11 post infection might delay priming of Mtb-specific CD4 T cells. To address this, we adoptively transferred naïve, Thy1.1-marked, ESAT-6-specific CD4 T cells (C7 T cells) into CCR2-DTR mice prior to aerosol Mtb infection ([@bib7]). Monocytes were depleted 7--11 days following infection, and mediastinal lymph nodes and lungs were harvested 12 and 21 days following infection. In comparison to mLNs obtained from PBS treated mice, mLNs obtained from monocyte-depleted mice were smaller, with significantly reduced total and CD4 T cell numbers ([Figure 2A](#fig2){ref-type="fig"}). C7 T cells had proliferated in mLNs of control mice 12 days after infection but had not expanded in monocyte-depleted mice ([Figure 2B,D](#fig2){ref-type="fig"}). Reduced C7 T cell proliferation in mLNs resulted in reduced C7 T cell frequencies in lungs of monocyte-depleted mice 21 days following infection ([Figure 2C,D](#fig2){ref-type="fig"}). Transfer of naïve C7 T cells to control mice resulted in a four to fivefold reduction of Mtb CFUs in lungs, suggesting that supplementing the endogenous T cell repertoire with additional naive, ESAT-6-specific CD4 T cells enhances immune defense against Mtb infection ([Figure 2E](#fig2){ref-type="fig"}). Depletion of monocytes abrogated enhanced protection resulting from addition of naive C7 T cells ([Figure 2E](#fig2){ref-type="fig"}).10.7554/eLife.01086.005Figure 2.Priming of ESAT-6-specific CD4 T cells is reduced in CCR2-DTR mice depleted during the second week of infection.(**A**) Total cell counts and CD4 T cell counts in mLNs of mice on day 12 post infection after treatment with DT or PBS on days 7, 9 and 11. CCR2-DTR mice received naive ESAT-6-specific C7 T cells the day before infection and were treated with DT or PBS on days 7, 9 and 11, mLNs (**B**) were harvested on day 12, lungs (**C**) were harvested on day 21 and ESAT-6-specific C7 T cells were visualized. (**D**) Cumulative data from experiments shown in (**B**) and (**C**) showing the total number of ESAT-6-specific C7 T cells in mLNs and lungs. (**E**) CFU plots of lungs of mice that received naive EAST-6-specific C7 T cells and were treated with DT or PBS, as indicated, and were harvested on day 21 post infection. Each dot represents an individual mouse. Five mice per group are included in the bar graphs shown in (**A**). Error bars denote SEM. Data are representative of three independent experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.01086.005](10.7554/eLife.01086.005)

Although IMs represent the most prevalent CCR2-expressing cell population, subsets of NK cells, dendritic cells and CD4 T cells can also express CCR2. To exclude the possibility that depletion of a non-monocyte cell population resulted in loss of Mtb transport from lungs to mLNs, we purified IMs from CCR2-GFP mice by sorting GFP+ cells that did not express NK1.1, CD4, FLT3 and C-kit. This strategy did not require antibody staining for trafficking molecules (CCR2 and CD11b) and eliminated NK cells, CD4 T cells, dendritic cell progenitors and hematopoietic stem cells, yielding a highly purified (\>99% pure) population of IMs ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). We adoptively transferred 2 × 10^6^ IMs on day 8 and 10 of infection while depleting CCR2+ cells on days 7, 9 and 11. The transferred IMs were detectable in lungs and mLNs and down-regulated expression of CCR2 and CD11b and up-regulated expression of MHC class II, CD11c and CD103 during trafficking from the lung to mLNs ([Figure 3A,B](#fig3){ref-type="fig"}). Administration of IMs to monocyte-depleted CCR2-DTR mice enhanced live Mtb transport to mLNs, as detected 12 days following infection ([Figure 3C](#fig3){ref-type="fig"}). Infusion of IMs to WT mice did not enhance delivery of Mtb to mLNs, suggesting that IMs are not limiting during the first 2 weeks of Mtb infection. Adoptive transfer of IMs to monocyte-depleted CCR2-DTR recipient mice rescued priming of C7 T cells ([Figure 3D,E](#fig3){ref-type="fig"}).10.7554/eLife.01086.006Figure 3.Adoptive transfer of highly purified inflammatory monocytes can rescue antigen transport and CD4 T cell priming in DT treated CCR2-DTR mice.CCR2-DTR mice were infected and treated with DT or PBS on days 7, 9 and 11 and received highly purified CD45.1+ IMs on days 8 and 10. (**A**) Mice were euthanized on day 12 post infection and flow cytometry was performed on lungs and mLNs to track the engraftment of adoptively transferred IMs. (**B**) The expression of cell surface markers CD11b, MHC II, CDIIc and CD103 by adoptively transferred IMs in the lung and mLN was determined. (**C**) CFU plots from day 12 mLNs of CCR2-DTR mice rescued with IMs. Dots marked in red represent mice that received double sorted IMs of greater than 99% purity. (**D**) CCR2-DTR mice received a dose of naive ESAT-6-specific C7 T cells the day before infection and were treated with DT on days 7, 9 and 11 and received purified IMs or PBS on days 8 and 10. Lungs were harvested on day 15 and ESAT-6-specific C7 T cells were visualized. (**E**) Cumulative data of experiment shown in (**D**) showing the total number of ESAT-6-specific C7 T cells in day 15 lungs. (**F**) CCR2-DTR mice were depleted on days 7, 9 and 11 and received CCR2 WT or CCR2 KO IMs on days 8 and 10. Day 12 mLNs were harvested for CFU counts. Each dot represents an individual mouse. Error bars denote SEM. Data are representative of two independent experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.01086.006](10.7554/eLife.01086.006)10.7554/eLife.01086.007Figure 3---figure supplement 1.Sorting of IMs from CCR2-GFP mice. FLT3-, cKit-, GFP+ cells were sorted from the bone marrow of CCR2-GFP mice.FACS plots show pre- and post sorting purity of the cells. Data are representative of two independent experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.01086.007](10.7554/eLife.01086.007)

While the CCR2 chemokine receptor is required for egress of IMs from bone marrow ([@bib21]), the role of CCR2 in trafficking of IMs into infected lungs or from the sites of lung infection to draining lymph nodes remains incompletely resolved. To determine whether CCR2 is required for trafficking to lungs and mLNs during Mtb infection, we purified IMs from CCR2-deficient, CCR2-GFP mice for adoptive transfer into Mtb-infected, CCR2-DTR recipient mice that were monocyte depleted between 7 and 11 days following infection. Quantitative culture 12 days following Mtb infection demonstrated that wild-type and CCR2-deficient IMs were equivalent at delivering Mtb to mLNs, indicating that CCR2-signaling does not contribute to trafficking of IMs between these sites ([Figure 3F](#fig3){ref-type="fig"}).

Although IMs acquired characteristics of dendritic cells and are essential for Mtb transport from infected lungs to mLNs, it remained unclear whether IMs directly primed Mtb-specific CD4 T cells. Therefore, we transferred C7 T cells into MHC class II-deficient CCR2-DTR mice, depleted monocytes 7--11 days following infection and adoptively transferred MHC class II-expressing purified monocytes on days 8 and 10 following infection. In contrast to our previous experiments with MHC class II-expressing recipients, C7 T cells were not primed in MHC class II-deficient recipients of MHC class II-expressing monocytes ([Figure 4A](#fig4){ref-type="fig"}). Adoptively transferred IMs trafficked to mLNs ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}) and, as demonstrated in the previous experiments, corrected Mtb delivery to draining lymph nodes to levels seen in mice that had not been monocyte-depleted ([Figure 4B](#fig4){ref-type="fig"}). Thus, defective antigen transport to the draining mLN could not explain the lack of CD4 T cell proliferation. In a reciprocal experiment, we transferred MHC class II-deficient IMs into Mtb-infected, MHC class II-expressing CCR2-DTR mice on the same schedule described above and quantified the C7 T cell response. [Figure 4C](#fig4){ref-type="fig"} demonstrates that the magnitude of the C7 T cell response was similar in monocyte-depleted mice rescued with either MHC class II-expressing or deficient monocytes. Taken together, these experiments indicate that IMs primarily serve as carriers of Mtb, delivering live bacteria to mLNs and enabling but not directly priming CD4 T cells.10.7554/eLife.01086.008Figure 4.IMs do not prime CD4 T cells directly.CCR2-DTR mice that were either MHC class II KO or WT received naive ESAT-6-specific C7 T cells the day before infection and were treated with DT or PBS on days 7, 9 and 11 and received purified IMs on days 8 and 10. (**A**) ESAT-6-specific C7 T cells in lungs harvested on day 15. (**B**) Mtb CFUs from mLNs of mice harvested on day 12. (**C**) CCR2-DTR mice received naive ESAT-6-specific C7 T cells the day before infection and were treated with DT or PBS on days 7, 9 and 11 and received either MHCII WT or MHCII KO IMs on days 8 and 10. Flow cytometry was performed on lungs harvested on day 15. (**D**) zDC-DTR mice received naive ESAT-6-specific C7 T cells the day before infection and cDCs were depleted on day 7, 9 and 11, and the number of ESAT-6-specific C7 T cells was determined in mLNs harvested on day 12. (**E**) The number of CFU in mLNs of PBS and DT treated zDC-DTR mice. (**F**) FLT3LKO mice received naive ESAT-6-specific C7 T cells the day before infection and lungs were harvested on day 15 to quantify the ESAT-6-specific C7 T cells. Each dot represents an individual mouse. Error bars denote SEM. Data are representative of two independent experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.01086.008](10.7554/eLife.01086.008)10.7554/eLife.01086.009Figure 4---figure supplement 1.Adoptively transferred IMs traffick to the mLNs of MHC Class II KO mice.MHC class II KO/CCR2-DTR mice infected with Mtb and depleted on days 7, 9, and 11 received a dose of purified IMs on days 8 and 10 and were harvested on day 12 when the total number of transferred IMs per mLN was quantified. Each group contains five mice. Data are representative of two independent experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.01086.009](10.7554/eLife.01086.009)10.7554/eLife.01086.010Figure 4---figure supplement 2.Priming of ESAT-6-specific C7 T cells is reduced in zDC-DTR mice.zDC-DTR mice received naive ESAT-6-specific C7 T cells the day before infection and cDCs were depleted on days 7, 9 and 11. On day 12 mLNs were harvested to quantify the number of ESAT-6-specific C7 T cells. Data are representative of two independent experiments containing four mice per group.**DOI:** [http://dx.doi.org/10.7554/eLife.01086.010](10.7554/eLife.01086.010)10.7554/eLife.01086.011Figure 4---figure supplement 3.Mtb traffick to the mLN of FLT3LKO mice is unimpaired.FLT3LKO mice were infected with Mtb and mLNs were harvested on day 12 for CFU analysis. Each dot represents an individual mouse. Data are representative of two independent experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.01086.011](10.7554/eLife.01086.011)

Classical DCs in lymph nodes and their progenitors express the cDC-specific transcription factor zbtb46, whereas IMs do not. To determine whether classical DCs are required for Mtb-specific CD4 T cell priming, we used zDC-DTR mice, in which DT administration leads to a loss of classical DC populations ([@bib12]; [@bib13]). We transferred C7 T cells into zDC-DTR mice, infected the mice with Mtb and administered DT on days 7--11 following infection. Depletion of classical DCs resulted in markedly reduced C7 T cell expansion ([Figure 4D](#fig4){ref-type="fig"}, [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}) but did not reduce the number of live Mtb in mLNs ([Figure 4E](#fig4){ref-type="fig"}). FLT3L-deficient mice, which lack classical DCs but not IMs, also have markedly reduced CD4 T cell responses following Mtb infection ([Figure 4F](#fig4){ref-type="fig"}) despite the presence of Mtb in the mLN ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}). These results indicate that classical DCs, while dispensable for trafficking of live Mtb from infected lungs to mLNs, are essential for CD4 T cell priming.

These experiments have refined our understanding of the role of IMs during the initiation of adaptive immune defense against *M. tuberculosis* infection. During the second week of murine infection, IMs play the critical role of delivering live Mtb to draining mLNs, an indispensable step for Mtb-specific CD4 T cell priming. Our results extend previous reports that IMs influence CD4 T cell priming ([@bib11]; [@bib8]; [@bib15]; [@bib18]) by demonstrating that IMs serve as transporters of live bacteria from the site of infection to the site of T cell priming.

In contrast to reports from other disease models demonstrating that IMs differentiate into DCs and then directly prime CD4 T cells ([@bib3]; [@bib25]) our adoptive transfer studies using MHC class II KO mice reveal that IMs, despite acquiring characteristics of DCs, do not prime Mtb-specific CD4 T cells in vivo. Why IMs fail to prime DCs in this setting remains unclear. Evidence that moDCs generated in vitro can stimulate T cell responses suggests that IMs can process and present antigen ([@bib19]). Recovery of several hundred adoptively transferred IMs from the mLNs of infected mice also suggests that sufficient numbers of IM were present to prime T cells. One possible explanation is that IMs, by virtue of being infected with Mtb, are ineffective at stimulating Mtb-specific lymphocytes, in contrast to resident dendritic cells that have not been infected ([@bib24]).

Antigen transport and T cell priming are often considered the two major functions of DCs. A number of studies, however, have demonstrated that multiple DC subsets can be involved in priming of naive T cells ([@bib9]). Other studies characterizing CD8 T cell responses to cutaneous viral infection have demonstrated a role for CD103+ DCs in transport and priming with potential contributions by inflammatory monocytes ([@bib2]; [@bib4]). One previous study has suggested that IMs carry fungal antigens from a site of cutaneous inoculation to draining LNs and transfer antigens to LN resident DCs ([@bib5]). Our study extends this finding to live pulmonary infection with Mtb. IMs transport bacteria to lymph nodes and transfer antigen to classical dendritic cells prior to CD4 T cell priming.

The mechanism of antigen transfer in mLNs remains undefined. It is possible that cross-dressing ([@bib23]), in which infected cells pass MHC molecules to uninfected cells, plays a role during Mtb infection. We did not detect transfer of MHC class II molecules from host cells to adoptively transferred, MHC class II-deficient monocytes. The number of MHC/peptide complexes required per APC to stimulate T cell responses, however, may be very small and below our level of detection. That said, given our finding that MHC class II-deficient IMs effectively complemented monocyte-depleted, MHC class II sufficient mice while MHC class II-expressing monocytes could not correct deficient T cell priming in MHC class II-deficient, monocyte-depleted mice, we believe that transfer of MHC class II molecules in either direction plays a minimal role in T cell priming during Mtb infection. Future studies will determine whether live Mtb are transferred to classical DCs, or whether transfer principally involves the movement of processed or unprocessed proteins from infected monocytes to uninfected DCs.

Materials and methods {#s3}
=====================

Mice {#s3-1}
----

C57BL/6 and MHC class II-deficient mice were purchased from the Jackson Laboratory. The generation of ESAT-6-specific C7 TCR transgenic, CCR2-DTR, CCR2-GFP and zDC-DTR mice were previously described ([@bib24]; [@bib7]; [@bib8]). For depletion experiments, mice were injected i.p. with 20 ng/g body weight DT. All mice were bred and maintained under specific pathogen-free conditions at the Memorial Sloan Kettering Research Animal Resource Center. Sex-and age-matched controls were used in all experiments according to institutional guidelines for animal care. All animal procedures were approved by the Institutional Animal Care and Use Committee of the Memorial Sloan-Kettering Cancer Center.

Aerosol infections with *M. tuberculosis* {#s3-2}
-----------------------------------------

*M. tuberculosis* Erdman was grown in 7H9 media, and log phase cultures were diluted to 8 × 10^6^ bacilli per millimeter and sonicated before infection with an aerosol exposure system (Glass-Col). The volume of suspension, and exposure time were calibrated to deliver ∼100 CFU per animal. To determine infection dose, three mice were killed 1 day after infection and lungs were homogenized in PBS/0.05% Tween-80, and half the lung homogenate was plated. At various intervals after infection the left lung was harvested from individual mice and homogenized in PBS/0.05% Tween-80. Serial dilutions were made in PBS/0.05% Tween-80 and plated onto Middlebrook 7H10 agar (BD Biosciences). After 3 weeks of incubation at 37°C in a 5% CO~2~ atmosphere, colonies were counted.

Adoptive IM transfer {#s3-3}
--------------------

Inflammatory monocytes were harvested from the bone marrow of CCR2-GFP mice. CD4 T cells and NK+ cells were removed using antibody depletion kits from Miltenyi Biotec. The remaining cells were then stained with anti FLT3 PE and anti C-kit PE antibodies and EGFP+, PE- cells were sorted by the Memorial Sloan-Kettering Cancer Center flow cytometry core facility. The cells were re-suspended in PBS and 2 × 10 ([@bib10]) cells per mouse were injected via the tail vein.

Statistics {#s3-4}
----------

All data are presented as the arithmetic mean ± SEM. Statistical validation was done with the Student's *t* test. p\<0.05 were considered significant, p\>0.05 were considered insignificant.
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Thank you for sending your work entitled "Essential yet limited role for CCR2^+^ inflammatory monocytes during Mycobacterium tuberculosis-specific T cell priming" for consideration at *eLife*. Your article has been favorably evaluated by a Senior editor and 2 reviewers, one of whom is a member of our Board of Reviewing Editors.

The Reviewing editor and the other reviewer discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.

This is an elegant and straightforward study that makes an important contribution on the role of different APCs in transport and presentation of antigen in vivo in a biologically relevant system.

The only open aspect is the mechanism of antigen transfer from inflammatory monocytes to resident DC. It would be interesting if the authors could provide insights on why the monocytes that carry Mtb to lymph nodes do not present antigen to CD4^+^ T cells. Is there a problem with their localization within lymph nodes? Or are they incompetent for antigen processing and presentation (their antigen presentation capacity could be tested ex vivo)? Or are they too few to function as APC and their role is limited to spreading a live organism? In addition the authors may also consider the alternative possibility that resident DCs transfer their MHC class II molecules to inflammatory monocytes (a process related to "cross dressing"). In this case DC depletion would block T cell activation because the source of MHC class II is absent. This possibility could be addressed by asking whether there is any MHC class II on class II KO inflammatory monocytes after adoptive transfer and infection. While these experiments would provide a mechanistic explanation to the results, they are not essential to support the major conclusions of the study and consequently the authors may address these issues in the Discussion.
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Author response

We thank the editor and reviewers for the review of our manuscript. We have addressed the major issues raised by the review with additional experiments and we have modified the Discussion of our manuscript. As pointed out, the mechanism of antigen transfer between monocytes and resident DCs remains unclear. Many in vitro studies have demonstrated the ability of monocyte-derived DCs to prime T cells, suggesting that IM-derived cells are not intrinsically incapable of antigen processing, presentation or T cell priming. Our ability to detect several hundred adoptively transferred IMs per mLN by flow cytometry suggests that a paucity of these cells is an unlikely explanation for their inability to prime T cells. We believe, and there is published evidence for this from other laboratories, that live Mtb infection interferes with MHC class II antigen processing and presentation. We have inserted statements in the Discussion to address these interesting possible explanations for our findings.

The reviewers also raised the possibility that our findings of CD4 T cell priming following transfer of MHC class II-deficient IMs might be explained by transfer of MHC molecules from mLN resident cells to IMs. Because this phenomenon, referred to as cross-dressing, might contribute to CD4 T cell priming during Mtb infection, we performed a repeat experiment in an attempt to detect MHC II molecules on MHC II-deficient IMs following their transfer into Mtb infected, MHC-class-expressing mice. Although we did not find evidence for cross-dressing using this approach, since it is possible that very few MHC molecules are required per cell for T cell priming, we are unable to rule out its contribution. That said, given our finding that MHC class II-deficient IMs effectively complemented monocyte-depleted, MHC class II sufficient mice while MHC class II-expressing monocytes could not correct deficient T cell priming in MHC class II-deficient, monocyte depleted mice, we believe that transfer of MHC class II molecules in either direction plays a minimal role in T cell priming during Mtb infection.

The manuscript has been corrected to reflect both the number of mice per experiment as well as the number of repetitions that were performed of each experiment.
